ECO 2026 12 - 15 May 2026

Treatment Effect of CagriSema 2.4 mg/2.4 mg in Adults With Early-Onset Overweight or Obesity in REDEFINE 1  

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Congress poster
Amylin
CagriSema
PHASE 3 (RCT)